STAT Plus: Pharmalittle: Lilly begins studying RA drug for Covid-19; AstraZeneca to provide Europe 400 million vaccine doses

Good morning, everyone, and welcome to another working week. We hope the weekend respite was somehow refreshing and relaxing, because that now-familiar routine of Zoom and Skype meetings has predictably returned. What can you do? Despite the crush of dizzying events, the world keeps spinning. So please join us as we cope with a delicious cup of stimulation. Our choice today is cinnamon dolce. Meanwhile, here is a fresh stack of tidbits for you to peruse. Hope your day goes well, and stay safe. …

Eli Lilly (LLY) has begun a study of its Olumiant rheumatoid arthritis drug in patients

Leave a Reply